Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)

China flag China · Delayed Price · Currency is CNY
13.76
-0.19 (-1.36%)
Sep 12, 2025, 2:45 PM CST
-1.36%
Market Cap2.42B
Revenue (ttm)243.21M
Net Income (ttm)-49.74M
Shares Out176.00M
EPS (ttm)-0.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,723,037
Average Volume2,813,969
Open14.12
Previous Close13.95
Day's Range13.75 - 14.12
52-Week Range5.77 - 17.49
Beta0.32
RSI39.76
Earnings DateAug 27, 2025

About SHE:002898

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pantoprazole sodium products, etc. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, prot... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 514
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002898
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.